Allis-Chalmers Energy, Inc. (NYSE:ALY) announced that it has established a record date and a meeting date for the special meeting of its stockholders to consider and vote upon, among other things, the proposal to adopt the previously announced Agreement and Plan of Merger, dated as of August 12, 2010, among Allis-Chalmers, Seawell Limited and Wellco Sub Company, pursuant to which Allis-Chalmers would become a subsidiary of Seawell.
Allis-Chalmers Energy Inc. provides services and equipment to oil and natural gas exploration and production companies in the United States.
Power3 Medical Products, Inc. (OTC:PWRM)
Parkinson's disease is a problem that affects nerve cells, or neurons, inside of a section of the brain which controls muscle motions. With Parkinson's, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist in synchronizing a person's activities.
As symptoms get worse, individuals with Parkinson's disease may have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking.
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
About Power3 Medical Products
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
To learn more about PWRM visit: http://www.Power3Medical.com
Pilgrim's Pride Corporation (NYSE:PPC) filed a Form 8-K with the Securities and Exchange Commission outlining the company's employment agreement and restricted stock agreement with William W. Lovette, who joined Pilgrim's as president and chief executive office on January 3, 2011.
Pilgrim's Pride Corporation produces poultry products in the United States, Mexico, and Puerto Rico.
Crown Equity Holdings Inc. (OTCPK:CRWE)
Due to the growth of information on the internet and the amount of time people use it, which has in turn created a new market for web-based advertising, some of the wealthiest businesses in the world have made sure that they get a portion of the internet marketing pie.
Crown Equity Holdings Inc. recently reported its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. CRWE incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by CRWE .
"Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business," commented Kenneth Bosket, President & CEO of Crown Equity Holdings Inc. "Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth," stated Bosket.
CRWE is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
CRWE is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused CRWE's primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
To learn more about CRWE visit: http://www.crownequityholdings.com
Harbinger Group Inc. (NYSE:HRG) announced that its majority-owned operating subsidiary Spectrum Brands Holdings, Inc. (NYSE:SPB) will issue its 2011 fiscal first quarter results and host a conference call and webcast on February 10, 2011.
Harbinger Group Inc. does not have significant operations. It intends to identify and evaluate business combinations or acquisitions of businesses. Previously, the company operated as a processor, marketer, and distributor of fish meal and fish oil products in the United States.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.